S-Alpha Therapeutics, Inc. To Present at Ophthalmology Innovation Summit During 2023 OIS@SECO in Atlanta, GA, USA

SAN FRANCISCO--(BUSINESS WIRE)--S-Alpha Therapeutics, Inc., a company developing new solutions for children with Myopia, announced today that Youngmin Huh, Ph.D., Data Science Leader, will present interim data from clinical trial using its novel, investigational device SAT-001 at Ophthalmology Innovation Summit held on 1st of March 2023, at OIS@SECO, Atlanta, GA, USA. SAT-001 is software as a medical device developed to improve pediatric myopia. SAT-001 employs a game interface that allows chil